Wound Care Advantage launches Advanced Discovery, an investigative research alliance that aims to evaluate a variety of diagnostic and treatment modalities with the goal of positively impacting wound healing outcomes while reducing treatment costs.

Collaborators in this alliance include the Southwestern Academic Limb Salvage Alliance (SALSA)—led by podiatric surgeon David G. Armstrong, DPM, MD, PhD—and Gen1 Research.

Advanced Discovery will offer access to an international network of advanced wound and hyperbaric treatment centers, and Gen1 will provide extensive administrative support and infrastructure for the studies.

By combining WCA and SALSA resources, Advanced Discovery will offer wound care product manufacturers a competitive advantage by providing access to extensive de-identified clinical data from a stable pool of participants. Advanced Discovery will harness electronic clinical data collected from more than 42,000 patients and 880,000 wound assessments over the past 16 years. Data will also be provided by SALSA, which has affiliations with universities and colleges around the world, including Keck School of Medicine at USC, explains a media release from Wound Care Advantage.

“By collaborating with Dr Armstrong and partnering with one of the world’s leading research teams, Advanced Discovery is poised to make a significant impact on the wound care industry,” says Mike Comer, CEO of Wound Care Advantage, in the release. “We’re committed to facilitating safe and ethical research, and always focusing on what’s best for the patient.”

“In the past, access to clinical studies and next-generation research was only available to a select few,” Armstrong states. “We’re upending that system and, in doing so, we can heal more patients and help them live better lives.

[Source(s): Wound Care Advantage, Business Wire]